Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
María Chaparro, Diana Acosta,Cristina Rodríguez,Francisco Mesonero, Miren Vicuña,Manuel Barreiro-de Acosta,Agnès Fernández-Clotet,Álvaro Hernández Martínez,Maite Arroyo,Isabel Vera,Alexandra Ruiz-Cerulla,Beatriz Sicilia, M José Cabello Tapia,Carmen Muñoz Villafranca,Jesús Castro-Poceiro, Jesús Martínez Cadilla,Mónica Sierra-Ausín,Juan María Vázquez Morón,Raquel Vicente Lidón,Fernando Bermejo,Vanesa Royo,Margalida Calafat,Carlos González-Muñoza,Eduardo Leo Carnerero,Noemi Manceñido Marcos,Leyanira Torrealba,Horacio Alonso-Galán,José Manuel Benítez,Yolanda Ber Nieto, M Teresa Diz-Lois Palomares,María José García,José Fernando Muñoz, Edisa María Armesto González,Xavier Calvet,Alejandro Hernández-Camba, Rosa Eva Madrigal Domínguez,Luis Menchén,José Lázaro Pérez Calle,Marta Piqueras,Carmen Dueñas Sadornil,Belén Botella,Teresa de Jesús Martínez-Pérez,Laura Ramos,María Carmen Rodríguez-Grau, Elena San Miguel,José Luis Fernández Forcelledo,Paola María Fradejas Salazar, Marifé García-Sepulcre,Ana Gutiérrez,Jordina Llaó, Eva Sesé Abizanda,Maia Boscá-Watts,Eduardo Iyo,Alma Keco-Huerga,Carmen Martínez Bonil,Elena Peña González,Pablo Pérez-Galindo,Pilar Varela,Javier P Gisbert The American journal of gastroenterology（2023）
摘要
Tofacitinib is effective in both short-term and long-term in patients with UC. The safety profile is similar to that previously reported.
更多查看译文
关键词
ulcerative colitis, tofacitinib, real-world evidence
AI 理解论文
溯源树
样例
